Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Fluticasone associated with more adrenal suppression than budesonide

March 13, 1997

SS Pharm./Torii developing new antiallergic agent

March 13, 1997

Novel LT biosynthesis inhibitor discovered by Abbott

March 11, 1997

Fluticasone + loratadine for seasonal allergic rhinitis

March 10, 1997

Spiros products progressing through pipeline

March 10, 1997

New PDE III/IV inhibitor described

March 10, 1997

HLE inhibitors from P&U

March 5, 1997

Antiallergic compounds disclosed by Meiji Seika

Feb. 28, 1997

PathoGenesis to seek approval for tobramycin

Feb. 27, 1997

Positive clinical results for inhaled indomethacin

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...